Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,304.00    -92.00 (-6.59%)
Bid:
1,298.00
Ask:
1,310.00
Spread: 12.00 (0.924%)
Market Cap: £597.63m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

SEA Wins ?3.5million contract

15 Jul 2010 12:29

RNS Number : 4134P
Cohort PLC
15 July 2010
 



15 July 2010 AIM: CHRT

PRESS RELEASE

COHORT PLC ("Cohort")

SEA Wins €3.5million contract for EarthCARE Programme

 

Cohort, the independent technology group, today announces that its wholly-owned subsidiary SEA has been selected by Surrey Satellite Technology Ltd. (SSTL) to provide an Instrument Control Unit (ICU) for the European Space Agency's EarthCARE mission, a contract valued at circa €3.5 million.

 

Under this contract, SEA will work alongside the prime, SSTL, to develop and produce the ICU for the Multi-Spectral Imager instrument on board the EarthCARE satellite, a €263 million joint Japanese-European project, which will be used to gain a better understanding of the interactions between cloud, radioactive and aerosol processes that play a role in climate regulation.

 

The Multi-Spectral Imager, which will collect images of the earth to support the measurement of cloud and aerosol properties, will rely on the ICU to collect scientific data and provide ground status commands whilst in flight.

 

SSTL is part of EADS Astrium the prime contractor for the EarthCARE satellite development. SEA is optimistic of further collaboration opportunities ahead of the satellite launch in 2013.

 

Commenting on the contract, Andrew Thomis, Chief Executive of Cohort plc, said:

 

"We are delighted to have secured this significant contract which is testament to the quality of our technology and capabilities. We continue to grow in the space market and look forward to further building our relationship with both SSTL and Astrium."

 

 

 

Ends

For further information, please contact

Cohort plc

 

Andrew Thomis, Chief Executive

Simon Walther, Finance Director

+44 (0)14 9184 5630

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

Hogarth

Reg Hoare, Vicky Watkins

+44 (0)20 7357 9477

 

 

Cohort plc (www.cohortplc.com)

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through three market-facing subsidiary companies:

 

·; MASS (www.mass.co.uk) - a specialist systems house with considerable experience in the defence market and a focus on Information Systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

·; SCS (www.scs-ltd.co.uk) - a defence consultancy, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

·; SEA (www.sea.co.uk) - an advanced surveillance systems and software house with hardware development capability operating in the defence, space, transport and offshore market sectors. Acquired by Cohort in October 2007.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Oxfordshire and, through its operating companies, employs in total around 500 core staff there and at bases in Bristol, Cambridgeshire, Oxfordshire, Lincolnshire and Somerset.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTEAFXSFAPEEFF
Date   Source Headline
10th Jul 202610:00 amRNS-REquity Development Webinar: Open to all investors
9th Jul 20267:00 amRNSNotice of Results
1st Jul 20264:43 pmRNSTotal Voting Rights
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.